Management of Incomplete Right Bundle Branch Block
Incomplete right bundle branch block (IRBBB) typically requires no specific treatment in asymptomatic individuals without underlying cardiac disease. 1
Definition and Significance
Incomplete right bundle branch block is characterized by:
- QRS duration between 110-119 ms in adults
- RSR' pattern in leads V1-V2
- S wave of greater duration than R wave or >40 ms in leads I and V6
- Normal R peak time in leads V5 and V6 but >50 ms in lead V1
Evaluation Algorithm
Initial Assessment:
- Determine if patient is symptomatic (lightheadedness, syncope, dyspnea)
- Check for family history of cardiac disease or sudden cardiac death
- Perform thorough cardiovascular examination (especially for split S2)
For Asymptomatic Patients:
- No specific treatment is required 1
- No routine follow-up testing needed unless other risk factors present
For Symptomatic Patients:
Special Considerations:
When to Consider Further Evaluation
Further cardiac evaluation is warranted in patients with IRBBB who have:
- Symptoms potentially attributable to bradycardia or heart block
- Signs of structural heart disease on physical examination
- Family history of premature cardiac disease or sudden cardiac death
- Coexisting left fascicular block (which may indicate more extensive conduction system disease) 1
Important Clinical Pitfalls
Differentiation from Pathological Conditions:
Medication Considerations:
- Avoid medications that can worsen conduction disorders, such as flecainide, in patients with IRBBB plus left fascicular block (bifascicular block) 4
- If flecainide therapy is discontinued if second or third-degree AV block develops, or if right bundle branch block associated with left hemiblock occurs 4
Progression Monitoring:
Conclusion
Incomplete right bundle branch block is generally a benign finding that requires no specific treatment in asymptomatic individuals. The focus should be on identifying any underlying cardiac conditions that may require treatment, particularly in symptomatic patients or those with additional conduction abnormalities.